M Perola Selected Research

Coronary Thrombosis

8/2001	Platelet glycoprotein Ibalpha HPA-2 Met/VNTR B haplotype as a genetic predictor of myocardial infarction and sudden cardiac death.
2/2001	The GPIIIa (beta3 integrin) PlA polymorphism in the early development of coronary atherosclerosis.
10/2000	Glycoprotein IIIa Pl(A1/A2) polymorphism and sudden cardiac death.
7/2000	Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Perola Research Topics

Disease

4	Coronary Thrombosis 08/2001 - 07/2000
3	Inflammation (Inflammations) 01/2019 - 02/2001
3	Atherosclerosis 06/2007 - 02/2001
3	Coronary Artery Disease (Coronary Atherosclerosis) 06/2007 - 02/2001
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 04/2006
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2011 - 03/2008
2	Sudden Death 06/2007 - 07/2000
2	Myocardial Infarction 08/2001 - 07/2000
2	Thrombosis (Thrombus) 08/2001 - 02/2001
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 08/2001 - 10/2000
1	Pre-Eclampsia (Preeclampsia) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Dementia (Dementias) 01/2019
1	Carcinogenesis 01/2019
1	Weight Gain 01/2018
1	Tobacco Use Disorder (Nicotine Dependence) 01/2017
1	Schizophrenia (Dementia Praecox) 01/2017
1	Neurodevelopmental Disorders 01/2017
1	Type 2 Diabetes Mellitus (MODY) 03/2011
1	Sepsis (Septicemia) 09/2010
1	Bacteremia 09/2010
1	Infections 09/2010
1	Osteoporosis 01/2009
1	Hypertension (High Blood Pressure) 06/2007
1	Coronary Stenosis (Coronary Artery Stenosis) 10/2001
1	Atherosclerotic Plaque (Atheroma) 09/2001
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 05/2001
1	Alzheimer Disease (Alzheimer's Disease) 10/2000

Drug/Important Bio-Agent (IBA)

3	C-Reactive ProteinIBA 01/2019 - 09/2010
2	CytokinesIBA 01/2021 - 02/2001
2	Glycoproteins (Glycoprotein)IBA 01/2019 - 10/2000
2	ApolipoproteinsIBA 06/2007 - 10/2000
2	Proteins (Proteins, Gene)FDA Link 09/2001 - 08/2001
2	Platelet Membrane GlycoproteinsIBA 08/2001 - 10/2000
2	Integrin beta3 (GPIIIa)IBA 02/2001 - 10/2000
2	Platelet Membrane Glycoprotein IIbIBA 02/2001 - 10/2000
1	Complement System Proteins (Complement)IBA 01/2021
1	Complement C3b (C3bi)IBA 01/2021
1	Complement Receptors (Complement Receptor)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	AcidsIBA 01/2019
1	HDL LipoproteinsIBA 01/2019
1	A-factor (Streptomyces)IBA 01/2018
1	Nicotine FDA Link 01/2017
1	NeuregulinsIBA 01/2017
1	Interleukin-1 (Interleukin 1)IBA 03/2011
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 03/2011
1	CalciumIBA 01/2009
1	CholesterolIBA 03/2008
1	Heparin (Liquaemin)FDA LinkGeneric 06/2007
1	Lipase (Acid Lipase)FDA Link 06/2007
1	ThrombomodulinIBA 04/2006
1	Silicone Elastomers (SE 30)IBA 10/2001
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 09/2001
1	Thrombin Receptors (Thrombin Receptor)IBA 08/2001
1	von Willebrand FactorIBA 08/2001
1	CollagenIBA 08/2001
1	ORALIT (ORS)IBA 08/2001
1	endotoxin receptorIBA 05/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2001
1	Protein Isoforms (Isoforms)IBA 10/2000
1	Fibrinogen ReceptorsIBA 10/2000
1	Apolipoproteins E (ApoE)IBA 10/2000
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2000
1	Plasminogen Activator Inhibitor 1IBA 07/2000

Therapy/Procedure

1	Home Nursing (Nursing, Home) 01/2019